Breaking News Instant updates and real-time market news.

EYEN

Eyenovia

$2.91 /

-0.07 (-2.35%)

16:13
04/22/20
04/22
16:13
04/22/20
16:13

Eyenovia files to sell 6.02M shares of common stock for holders

EYEN Eyenovia
$2.91 /

-0.07 (-2.35%)

03/26/20 H.C. Wainwright
Eyenovia price target lowered to $6 from $10 at H.C. Wainwright
02/03/20 Oppenheimer
Eyenovia downgraded to Perform from Outperform at Oppenheimer
10/30/19 H.C. Wainwright
Eyenovia price target lowered to $10 from $12 at H.C. Wainwright
04/25/19
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Syndicate
Treace Medical indicated to open at $22, IPO priced at $17 » 10:36
04/23/21
04/23
10:36
04/23/21
10:36
TMCI

Treace Medical

/

+

Treace Medical Concepts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 23
    Apr
Hot Stocks
AnaptysBio granted conditional marketing authorization for JEMPERLI » 10:36
04/23/21
04/23
10:36
04/23/21
10:36
ANAB

AnaptysBio

$23.51 /

+0.63 (+2.75%)

, GSK

GlaxoSmithKline

$37.58 /

-0.1 (-0.27%)

AnaptysBio (ANAB)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 Truist
AnaptysBio upgraded to Buy from Hold at Truist
03/16/21 Truist
AnaptysBio upgraded to Buy from Hold at Truist
03/09/21 Wedbush
AnaptysBio downgraded to Neutral at Wedbush
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
03/23/21
Fly Intel: Top five analyst downgrades
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

Options
Rite Aid put volume heavy and directionally bearish » 10:35
04/23/21
04/23
10:35
04/23/21
10:35
RAD

Rite Aid

$18.33 /

+0.14 (+0.77%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

03/25/21 Deutsche Bank
Rite Aid price target raised to $27 from $17 at Deutsche Bank
03/25/21 Deutsche Bank
Rite Aid named short-term buy idea at Deutsche Bank
12/18/20 Deutsche Bank
Rite Aid price target raised to $17 from $9 at Deutsche Bank
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

General news
Oil Action: WTI crude » 10:35
04/23/21
04/23
10:35
04/23/21
10:35
$ECON

Economic Data

/

+

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Inter Pipeline price target raised to C$18 from C$17.50 at Scotiabank » 10:34
    04/23/21
    04/23
    10:34
    04/23/21
    10:34
    IPPLF

    Inter Pipeline

    $14.50 /

    +0.2918 (+2.05%)

    Scotiabank analyst Robert…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IPPLF Inter Pipeline
    $14.50 /

    +0.2918 (+2.05%)

    IPPLF Inter Pipeline
    $14.50 /

    +0.2918 (+2.05%)

    07:39 Today Stifel
    Inter Pipeline downgraded to Hold at Stifel on strategic review uncertainty
    04/22/21 Stifel
    Inter Pipeline downgraded to Hold from Buy at Stifel
    04/06/21 Stifel
    Inter Pipeline price target raised to C$20.50 from C$20 at Stifel
    02/24/21 National Bank
    Inter Pipeline price target raised to C$18 from C$15 at National Bank
    Recommendations
    CGI Inc. price target raised to C$112 from C$106 at Scotiabank » 10:34
    04/23/21
    04/23
    10:34
    04/23/21
    10:34
    GIB

    CGI Inc.

    $85.50 /

    -0.02 (-0.02%)

    Scotiabank analyst Paul…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    04/12/21 Societe Generale
    CGI Inc. upgraded to Hold from Sell at Societe Generale
    03/23/21 Desjardins
    CGI Inc. resumed with a Buy at Desjardins
    03/04/21 Edward Jones
    CGI Inc. upgraded to Buy from Hold at Edward Jones
    02/01/21 Barclays
    CGI Inc. price target raised to $89 from $80 at Barclays
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    Syndicate
    Rain Therapeutics indicated to open at $27, IPO priced at $17 » 10:33
    04/23/21
    04/23
    10:33
    04/23/21
    10:33
    RAIN

    Rain Therapeutics

    /

    +

    Rain Therapeutics (RAIN)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    • 23
      Apr
    Syndicate
    Latham Group indicated to open at $22, IPO priced at $19 » 10:32
    04/23/21
    04/23
    10:32
    04/23/21
    10:32
    SWIM

    Latham Group

    /

    +

    Latham Group (SWIM)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    • 23
      Apr
    SWIM Latham Group
    /

    +

    Options
    Bristol Myers Squibb call volume above normal and directionally bullish » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25
    BMY

    Bristol-Myers

    $66.89 /

    +0.57 (+0.86%)

    Bullish option flow…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/21/21 Citi
    Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
    04/21/21 Citi
    Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
    04/13/21 Truist
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
    04/13/21 Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    Conference/Events
    Cowen pharmaceuticals analysts to hold analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25
    BMY

    Bristol-Myers

    $66.89 /

    +0.57 (+0.86%)

    Pharmaceuticals Analysts…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/21/21 Citi
    Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
    04/21/21 Citi
    Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
    04/13/21 Truist
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
    04/13/21 Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    Conference/Events
    Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Large Cap & Biopharma…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Conference/Events
    UBS technology analyst to hold an analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Technology Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Conference/Events
    Truist digital advertising analysts to hold analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Digital Ad Analysts,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Hot Stocks
    Allegiance Bancshares approves stock repurchase authorization up to 1M shares » 10:24
    04/23/21
    04/23
    10:24
    04/23/21
    10:24
    ABTX

    Allegiance Bancshares

    $39.02 /

    + (+0.00%)

    On April 22, 2021, the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10/02/20 Janney Montgomery Scott
    Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    Recommendations
    WeCommerce price target lowered to C$23 from C$26 at TD Securities » 10:23
    04/23/21
    04/23
    10:23
    04/23/21
    10:23
    WECMF

    WeCommerce

    $14.79 /

    +0.4312 (+3.00%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Hot Stocks
    Allegiance Bancshares appoints Raimundo Riojas to board of directors » 10:23
    04/23/21
    04/23
    10:23
    04/23/21
    10:23
    ABTX

    Allegiance Bancshares

    $39.02 /

    + (+0.00%)

    Allegiance Bancshares…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10/02/20 Janney Montgomery Scott
    Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    Recommendations
    Intact Financial price target raised to C$185 from C$175 at TD Securities » 10:22
    04/23/21
    04/23
    10:22
    04/23/21
    10:22
    IFCZF

    Intact Financial

    $130.32 /

    -0.03 (-0.02%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IFCZF Intact Financial
    $130.32 /

    -0.03 (-0.02%)

    02/12/21 Desjardins
    Intact Financial price target raised to C$175 from C$170 at Desjardins
    02/10/21 National Bank
    Intact Financial price target raised to C$200 from C$192 at National Bank
    02/10/21 TD Securities
    Intact Financial price target raised to C$175 from C$170 at TD Securities
    12/08/20 Scotiabank
    Intact Financial price target raised to C$175 from C$166 at Scotiabank
    Hot Stocks
    GlaxoSmithKline reports European Commission approves Jemperli » 10:22
    04/23/21
    04/23
    10:22
    04/23/21
    10:22
    GSK

    GlaxoSmithKline

    $37.65 /

    -0.03 (-0.08%)

    GlaxoSmithKline announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    04/20/21 Morgan Stanley
    GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
    04/20/21 UBS
    GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
    04/20/21 Citi
    GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
    03/23/21
    Fly Intel: Top five analyst downgrades
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    Recommendations
    Walmart+ members may have declined to 11.1M in March, says Cowen » 10:21
    04/23/21
    04/23
    10:21
    04/23/21
    10:21
    WMT

    Walmart

    $139.75 /

    +0.08 (+0.06%)

    Cowen analyst Oliver Chen…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    WMT Walmart
    $139.75 /

    +0.08 (+0.06%)

    WMT Walmart
    $139.75 /

    +0.08 (+0.06%)

    04/06/21 Morgan Stanley
    Walmart+ membership 'seems to have stagnated,' says Morgan Stanley
    03/16/21 MKM Partners
    Walmart price target lowered to $141 from $154 at MKM Partners
    02/23/21 Evercore ISI
    Walmart accelerating change with investments, says Evercore ISI
    02/19/21 Morgan Stanley
    Walmart terminal value rising with investments, says Morgan Stanley
    WMT Walmart
    $139.75 /

    +0.08 (+0.06%)

    WMT Walmart
    $139.75 /

    +0.08 (+0.06%)

    WMT Walmart
    $139.75 /

    +0.08 (+0.06%)

    WMT Walmart
    $139.75 /

    +0.08 (+0.06%)

    Recommendations
    Well Health Technologies price target raised to C$10.50 from C$10 at TD Securities » 10:19
    04/23/21
    04/23
    10:19
    04/23/21
    10:19
    WLYYF

    Well Health Technologies

    $5.50 /

    -0.1591 (-2.81%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    WLYYF Well Health Technologies
    $5.50 /

    -0.1591 (-2.81%)

    03/19/21 TD Securities
    Well Health price target lowered to C$10 from C$11 at TD Securities
    03/10/21 Desjardins
    Well Health Technologies upgraded to Buy from Hold at Desjardins
    02/18/21 Stifel
    Well Health Technologies price target raised to C$13.50 from C$10 at Stifel
    02/10/21 Desjardins
    Well Health Technologies downgraded to Hold from Buy at Desjardins
    Recommendations
    Superior Plus price target raised to C$16.50 from C$15.50 at TD Securities » 10:19
    04/23/21
    04/23
    10:19
    04/23/21
    10:19
    SUUIF

    Superior Plus

    $11.79 /

    -0.0109 (-0.09%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SUUIF Superior Plus
    $11.79 /

    -0.0109 (-0.09%)

    05:00 Today Industrial Alliance
    Superior Plus downgraded to Hold from Buy at Industrial Alliance
    02/22/21 BMO Capital
    Superior Plus price target raised to C$12.50 from C$12 at BMO Capital
    02/19/21 TD Securities
    Superior Plus price target raised to C$15.50 from C$14.50 at TD Securities
    02/19/21 Scotiabank
    Superior Plus price target raised to C$15 from C$13 at Scotiabank
    Technical Analysis
    NASDAQ market internals summary » 10:17
    04/23/21
    04/23
    10:17
    04/23/21
    10:17
    $NSD

    NASDAQ Market Internals

    /

    +

    Volume is above average…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $NSD NASDAQ Market Internals
    /

    +

    Technical Analysis
    NYSE market internals summary » 10:16
    04/23/21
    04/23
    10:16
    04/23/21
    10:16
    $NYE

    NYSE Market Internals

    /

    +

    Volume is average for…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    $NYE NYSE Market Internals
    /

    +

    Hot Stocks
    Sanofi announces presentation of Dupixent analyses on safety, efficacy » 10:15
    04/23/21
    04/23
    10:15
    04/23/21
    10:15
    SNY

    Sanofi

    $51.48 /

    -0.57 (-1.10%)

    New analyses from…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SNY Sanofi
    $51.48 /

    -0.57 (-1.10%)

    SNY Sanofi
    $51.48 /

    -0.57 (-1.10%)

    04/06/21 Barclays
    Sanofi price target raised to EUR 85 from EUR 80 at Barclays
    02/23/21 BofA
    BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
    02/10/21 Morgan Stanley
    Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
    02/05/21 Piper Sandler
    Piper reiterates Overweight on Kymera after Sanofi capital markets day
    SNY Sanofi
    $51.48 /

    -0.57 (-1.10%)

    SNY Sanofi
    $51.48 /

    -0.57 (-1.10%)

    SNY Sanofi
    $51.48 /

    -0.57 (-1.10%)

    General news
    FX Action: The dollar » 10:15
    04/23/21
    04/23
    10:15
    04/23/21
    10:15
    $ECON

    Economic Data

    /

    +

    FX Action: The dollar was…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<

      Get Full Fly Access

      Breaking market intelligence sent straight to you
      Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
      Up-to-date information on important industry events
      Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
      News focused on the companies in your portfolio
      Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.